SynthesisFrontiers in psychology2026
Effectiveness of solution-focused brief therapy on cancer patients: a systematic review and meta-analysis.
Synthesis in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The aim of this study was to review and meta-analyze the effectiveness of a nursing intervention based on solution-focused brief therapy (SFBT) in improving anxiety, depression, cancer-related fatigue, and quality of life in cancer patients. Methods: Conducting a systematic evaluation and meta-analysis following the PRISMA guidelines, we performed a thorough search across various databases including Cochrane, PubMed, CINAHL, PsycInfo, EMBASE, CNKI, Wanfang Database, and VIP Database. The search was conducted from the inception of each database up to February 2024. The overall effect size of the intervention was determined by calculating the standardized mean difference (SMD) and its 95% confidence interval. Statistical analyses were conducted using Review Manager (RevMan) 5.4.1. Results: 13 studies meeting the selection criteria were included, encompassing a total of 1146 patients in the final analysis. 8 research examined the impact on anxiety, 10 on depression, 6 on cancer-related fatigue, and 5 on quality of life. The standardized mean difference for anxiety was -1.52 (CI: -2.20 ∼ -0.84, Conclusion: SFBT may be effective in reducing anxiety, depression, cancer-related fatigue and improving quality of life in cancer patients. However, due to the limitations of the original study, including a high risk of bias and significant heterogeneity, although the research results are encouraging, the overall quality of existing evidence is low, so we cannot draw clear conclusions. More robust research designs are needed to accurately evaluate the effects of this treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.